GITAM University is overhauling its pharmacy curriculum to include AI and Machine Learning, signaling a massive shift in India’s pharma talent pipeline. This move aims to turn the 'Pharmacy of the World' into a global leader in data-driven drug discovery.
India is pivoting its ₹1.5 lakh crore pharmaceutical engine toward AI-driven drug discovery to defeat global superbugs. By merging Nvidia-powered computing with sovereign data, the nation is moving from generic manufacturing to high-value IP creation.
Researchers have used Generative AI to design 'super-antibiotics' that could solve the global drug-resistance crisis. For India's ₹1.5 lakh crore pharma sector, this marks a shift from manufacturing generics to leading the world in AI-driven drug discovery.
Mark Zuckerberg is betting $500 million on an AI Biohub designed to create a digital twin of every human cell. This cellular 'GPS' could revolutionize drug discovery for India's pharmaceutical titans.
